Disabled at heart of new funding model

A new disability support system, including a new funding model, will be trialled from 1 October in the MidCentral District Health Board (DHB).The new Enabling...

Clareon comes to Tauranga

Since the recent launch of Alcon’s world-first AutonoMe preloaded IOL delivery system with the Clareon intraocular lens (IOL) in Sydney, several ophthalmologists...

Practice intelligence: What gets measured, gets done

Today’s practice owner has access to more information and insights into how the practice is performing than ever before. With a focused approach, you will...

Antiparasitic efficacy of eyelid cleansers for Demodex blepharitis

Ocular surface infestation with Demodex mites is recognised as a significant risk factor for the development of chronic blepharitis. Although 50% tea tree...

Out and about

Like most folk I always regarded walking from A to B as a fairly mundane but pleasant way of getting around, until recently. Now, sadly it’s a combination...

Ocular manifestations in Down Syndrome

Down Syndrome (DS), trisomy of chromosome 21, is one of the most common genetic causes of intellectual disability. It affects 50-80 newborns annually in...

AMD stem cell trials and big data

Phase I clinical study of an embryonic stem cell–derived retinal pigment epithelium patch; Transplantation of human embryonic stem cell-derived retinal...

To AREDS or not…?

The Age-Related Eye Disease Study (AREDS) study in 2001 and the AREDS2 study (2013), recommend that patients with intermediate stage age-related macular...

Bottom Banner Advert